 |
The Journal of Neuroscience, October 29, 2003, 23(30):9796-9804
Previous Article | Next Article 
Cellular/Molecular
Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor- Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of -Secretase
Magdalena Sastre,1
Ilse Dewachter,2
Gary E. Landreth,3
Timothy M. Willson,4
Thomas Klockgether,1
Fred van Leuven,2 and
Michael T. Heneka1
1Department of Neurology, University of Bonn, 53127 Bonn, Germany, 2Department of Human Genetics, Experimental Genetics Group, B-3000 Leuven, Belgium, 3Alzheimer Laboratory, Case Western Reserve University, Cleveland, Ohio 44106-4928, and 4GlaxoSmithKline, Discovery Research, Research Triangle Park, North Carolina 27709
Long-term treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk for Alzheimer's disease (AD). To determine the mechanisms by which inflammation affects AD and how NSAIDs protect against it, we stimulated neuroblastoma cells stably transfected with amyloid precursor protein (APP) with proinflammatory cytokines, which increased the secretion of amyloid- and APP ectodomain. Addition of ibuprofen, indomethacin, peroxisome proliferator-activated receptor- (PPAR ) agonists, or cotransfection with PPAR cDNA reversed this effect. The inhibitory action of ibuprofen and indomethacin was suppressed by PPAR antagonists. Finally, we observed that the mRNA levels, expression, and enzymatic activity of -secretase were increased by immunostimulation and normalized by NSAIDs. In conclusion, proinflammatory cytokines activate -secretase, and NSAIDs inhibit this effect through PPAR .
Key words: cytokine; amyloid precursor protein (APP); amyloid- ; NSAIDs; ibuprofen; PPAR- ; BACE1
Received May 21, 2003;
revised August 26, 2003;
accepted August 28, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
A. V. Woodard-Grice, A. C. McBrayer, J. K. Wakefield, Y. Zhuo, and S. L. Bellis
Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of {alpha}4{beta}1 Integrins
J. Biol. Chem.,
September 26, 2008;
283(39):
26364 - 26373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wang and Y.-J. Y. Wan
Nuclear Receptors and Inflammatory Diseases
Experimental Biology and Medicine,
May 1, 2008;
233(5):
496 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Heneka, M. Ramanathan, A. H. Jacobs, L. Dumitrescu-Ozimek, A. Bilkei-Gorzo, T. Debeir, M. Sastre, N. Galldiks, A. Zimmer, M. Hoehn, et al.
Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice
J. Neurosci.,
February 1, 2006;
26(5):
1343 - 1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sastre, I. Dewachter, S. Rossner, N. Bogdanovic, E. Rosen, P. Borghgraef, B. O. Evert, L. Dumitrescu-Ozimek, D. R. Thal, G. Landreth, et al.
Nonsteroidal anti-inflammatory drugs repress {beta}-secretase gene promoter activity by the activation of PPAR{gamma}
PNAS,
January 10, 2006;
103(2):
443 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Townsend and D. Pratico
Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs
FASEB J,
October 1, 2005;
19(12):
1592 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, C. Kuiperi, K. O'Banion, T. Klockgether, F. Van Leuven, and G. E. Landreth
Acute treatment with the PPAR{gamma} agonist pioglitazone and ibuprofen reduces glial inflammation and A{beta}1-42 levels in APPV717I transgenic mice
Brain,
June 1, 2005;
128(6):
1442 - 1453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Lim, F. Calon, T. Morihara, F. Yang, B. Teter, O. Ubeda, N. Salem Jr, S. A. Frautschy, and G. M. Cole
A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model
J. Neurosci.,
March 23, 2005;
25(12):
3032 - 3040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cordle and G. Landreth
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate {beta}-Amyloid-Induced Microglial Inflammatory Responses
J. Neurosci.,
January 12, 2005;
25(2):
299 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Lanz, G. J. Fici, and K. M. Merchant
Lack of Specific Amyloid-{beta}(1-42) Suppression by Nonsteroidal Anti-Inflammatory Drugs in Young, Plaque-Free Tg2576 Mice and in Guinea Pig Neuronal Cultures
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
399 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. E. Camacho, L. Serneels, K. Spittaels, P. Merchiers, D. Dominguez, and B. De Strooper
Peroxisome Proliferator-Activated Receptor {gamma} Induces a Clearance Mechanism for the Amyloid-{beta} Peptide
J. Neurosci.,
December 1, 2004;
24(48):
10908 - 10917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhou, C. Noviello, C. D'Ambrosio, A. Scaloni, and L. D'Adamio
Growth Factor Receptor-bound Protein 2 Interaction with the Tyrosine-phosphorylated Tail of Amyloid {beta} Precursor Protein Is Mediated by Its Src Homology 2 Domain
J. Biol. Chem.,
June 11, 2004;
279(24):
25374 - 25380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mouihate, L. Boisse, and Q. J. Pittman
A Novel Antipyretic Action of 15-Deoxy-{Delta}12,14-Prostaglandin J2 in the Rat Brain
J. Neurosci.,
February 11, 2004;
24(6):
1312 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|